<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12-antibodies-09-00020">
 <label>12.</label>
 <element-citation publication-type="confproc">
  <person-group person-group-type="author">
   <name>
    <surname>Desheva</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Rudenko</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Rekstin</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Swayne</surname>
    <given-names>D.E.</given-names>
   </name>
   <name>
    <surname>Cox</surname>
    <given-names>N.J.</given-names>
   </name>
   <name>
    <surname>Klimov</surname>
    <given-names>A.I.</given-names>
   </name>
  </person-group>
  <article-title>Development of candidate H7N3 live attenuated cold–adapted influenza vaccine</article-title>
  <source>Proceedings of the International Conference on Options for the Control of Influenza VI</source>
  <conf-loc>Toronto, ON, Canada</conf-loc>
  <conf-date>17–23 June 2007</conf-date>
 </element-citation>
</ref>
